UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹104 Cr | ₹99 Cr | ₹92 Cr | ₹108 Cr | ₹144 Cr |
What is the latest Total Non-Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹104 Cr |
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹108 Cr |
| Mar2022 | ₹144 Cr |
How is Total Non-Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹104 Cr | 4.84 | |
| Mar2025 | ₹99 Cr | 6.99 | |
| Mar2024 | ₹92 Cr | -14.59 | |
| Mar2023 | ₹108 Cr | -24.92 | |
| Mar2022 | ₹144 Cr | - | |
Compare Total Non-Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,783.6 Cr | -5.6% | -1.3% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -5.6% |
-1.3% |
5.7% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses